The global sports medicine market was valued at USD 6.26 billion in 2018 and is projected to grow to USD 13.86 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.8% over the forecast period. In 2018, North America held the largest share of the global sports medicine market, accounting for 41.53%.